OpGen, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (16)

View All

Latest Posts

About This Stock More About This Stock
Protalix BioTherapeutics Announces FDA Acceptance Of BLA For The Treatment Of Fabry Disease And Grants Priority Review
Article By: TalkMarkets Newswire
Tuesday, August 11, 2020 9:05 AM EDT
Priority Review is granted to therapies that the FDA determines have the potential to provide significant improvements in the treatment, diagnosis or prevention of serious conditions.
In this article: PLX Also: IMMP, SRNE, TTOO, OPGN, OXBR
Read
Stock Charts To Watch - Monday March 16
Video By: Harry Boxer
Monday, March 16, 2020 9:49 PM EDT
American Airlines Group Inc. did well on Monday, forming an engulfing, bullish, reversal bar on 1.61, or 11%, to 16.20, before pulling back and closing up 15.92, on 83.2 million shares traded.
In this video: VIR, APT, OPGN, AHPI, AAL
Watch
The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance
Article By: Benzinga
Friday, November 1, 2019 7:38 AM EDT
Here's a roundup of top developments in the biotech space over the last 24 hours.
In this article: AMGN, BGNE, MNK, PRTK, IDYA, CDNA, BLUE Also: HOTH, AGN, AZN, BMY, GSK, RMD, ACOR, ACRX, ALIM, AMAG, BCRX, CERS, IMGN, NURO, RMTI, CELG, VRTX, ABBV, AGIO, REPH, RETA, PRTO, MGNX, OPGN, MGEN, DOVA, DRNA, DCPH, TRVI, OYST, RAPT, ARDS, MIRM, ITRM, COCP, CYCN, GMAB
Read
All Posts

Latest Tweets for $OPGN

No tweets yet!

PARTNER HEADLINES